NCT01662310 – Paliperidone Extended Release Tablets for the Prevention of Relapse in Subjects With Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Posted on March 31, 2016 by tsuperadmin -
NCT01193153 – A Randomized, Double-Blind, Placebo-Controlled, Parellel-Group Study of Paliperidone Palmitate Evaluating Time to Relapse in Subjects With Schizoaffective Disorder Posted on March 31, 2016 by tsuperadmin -
NCT01529515 – A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia Posted on March 31, 2016 by tsuperadmin -
The safety and efficacy of risperidone 8 mg qd and 4 mg qd compared to placebo in the treatment of schizophrenia Posted on March 31, 2016 by tsuperadmin -
NCT00253123 – A Randomized, Double-Blind, Placebo-Controlled Study of Risperidone for Treatment of Behavioral Disturbances in Subjects With Dementia Posted on March 31, 2016 by tsuperadmin -
The efficacy and safety of flexible dose ranges of risperidone vs. Placebo or divalproex sodium in the treatment of manic or mixed episodes associated with bipolar 1 disorder Posted on March 31, 2016 by tsuperadmin -
NCT00257075 – The Efficacy And Safety Of Flexible Dosage Ranges Of Risperidone Versus Placebo In The Treatment Of Manic Episodes Associated With Bipolar I Disorder Posted on March 31, 2016 by tsuperadmin -
NCT00034762 – Efficacy And Safety Of A Flexible Dose Of Risperidone Versus Placebo In The Treatment Of Psychosis Of Alzheimer’s Disease Posted on March 31, 2016 by tsuperadmin -
A double-blind, placebo-controlled study of risperidone in children and adolescents with autistic disorder Posted on March 31, 2016 by tsuperadmin -
NCT00253136 – Risperidone Depot (Microspheres) vs. Placebo in the Treatment of Subjects With Schizophrenia Posted on March 31, 2016 by tsuperadmin -
The YODA Project